BOSTON & PERTH, Australia--(BUSINESS WIRE)--May 24, 2006--Global bio-nanotech company pSivida Limited (ASX:PSD - News; NASDAQ:PSDV - News; Xetra:PSI - News) today confirmed that the despatch to eligible shareholders of the Rights Issue prospectus and entitlement and acceptance forms was completed today.
